132 related articles for article (PubMed ID: 7852048)
1. Cardiac allografts in rat recipients with simultaneous use of anti-ICAM-1 and anti-LFA-1 monoclonal antibodies leads to accelerated graft loss.
Morikawa M; Tamatani T; Miyasaka M; Uede T
Immunopharmacology; 1994; 28(3):171-82. PubMed ID: 7852048
[TBL] [Abstract][Full Text] [Related]
2. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
[TBL] [Abstract][Full Text] [Related]
3. Effect of anti-intercellular adhesion molecule-1 and anti-leukocyte function associated antigen-1 monoclonal antibodies on rat-to-mouse cardiac xenograft rejection.
Miwa S; Isobe M; Suzuki J; Makuuchi M; Miyasaka M; Yamazaki S; Kawasaki S
Surgery; 1997 Jun; 121(6):681-9. PubMed ID: 9186469
[TBL] [Abstract][Full Text] [Related]
4. Treatment with monoclonal antibodies to ICAM-1 and LFA-1 in rat heart allograft rejection.
Brandt M; Steinmann J; Steinhoff G; Haverich A
Transpl Int; 1997; 10(2):141-4. PubMed ID: 9090001
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies of free and vascularized skin allograft rejection.
Iwata T; Kamei Y; Esaki S; Takada T; Torii S; Yamashita A; Tomida S; Tamatani T; Miyasaka M; Yoshikai Y
Immunobiology; 1996 Jul; 195(2):160-71. PubMed ID: 8877393
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation.
Suzuki J; Isobe M; Yamazaki S; Horie S; Okubo Y; Sekiguchi M
J Heart Lung Transplant; 1997 Nov; 16(11):1141-8. PubMed ID: 9402514
[TBL] [Abstract][Full Text] [Related]
7. The role of cell adhesion molecules in allograft rejection after penetrating keratoplasty in mice. Clinical and immunohistochemical study.
Yamagami S; Tsuru T; Isobe M; Obata H; Suzuki J
Graefes Arch Clin Exp Ophthalmol; 1996 Jun; 234(6):382-7. PubMed ID: 8738705
[TBL] [Abstract][Full Text] [Related]
8. Induction of donor-specific tolerance to rat nerve allografts with portal venous donor alloantigen and anti-ICAM-1/LFA-1 monoclonal antibodies.
Genden EM; Mackinnon SE; Yu S; Flye MW
Surgery; 1998 Aug; 124(2):448-56. PubMed ID: 9706170
[TBL] [Abstract][Full Text] [Related]
9. Limb allografts in rats treated with anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
Tsuchida Y; Usui M; Naitoh T; Takahashi T; Murakami M; Uede T
J Reconstr Microsurg; 1997 Feb; 13(2):107-10. PubMed ID: 9044184
[TBL] [Abstract][Full Text] [Related]
10. Transplantation tolerance by a combined therapy with sulfatide, anti-LFA-1/ICAM-1 monoclonal antibodies and FK506 in rat cardiac transplantation.
Horimoto H; Ito T; Hayashi T; Miyasaka M; Nozawa M
Transpl Int; 1998; 11 Suppl 1():S310-2. PubMed ID: 9665003
[TBL] [Abstract][Full Text] [Related]
11. Combination of anti-ICAM-1 and anti-LFA-1 monoclonal antibody therapy prolongs allograft survival in rat hind-limb transplants.
Ozer K; Siemionow M
J Reconstr Microsurg; 2001 Oct; 17(7):511-7; discussion 518. PubMed ID: 11598825
[TBL] [Abstract][Full Text] [Related]
12. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1.
Isobe M; Yagita H; Okumura K; Ihara A
Science; 1992 Feb; 255(5048):1125-7. PubMed ID: 1347662
[TBL] [Abstract][Full Text] [Related]
13. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade.
Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L
Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092
[TBL] [Abstract][Full Text] [Related]
14. Assessment of tolerance induction to cardiac allograft by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
Isobe M; Suzuki J; Yamazaki S; Horie S; Okubo Y; Sekiguchi M
J Heart Lung Transplant; 1997 Nov; 16(11):1149-56. PubMed ID: 9402515
[TBL] [Abstract][Full Text] [Related]
15. Direct antigen presentation through binding of donor intercellular adhesion molecule-1 to recipient lymphocyte function-associated antigen-1 molecules in xenograft rejection.
Ohta Y; Gotoh M; Ohzato H; Fukuzaki T; Nishihara M; Dono K; Umeshita K; Sakon M; Yagita H; Okumura K; Tanaka T; Kawashima H; Miyasaka M; Monden M
Transplantation; 1998 Apr; 65(8):1094-100. PubMed ID: 9583871
[TBL] [Abstract][Full Text] [Related]
16. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival.
He Y; Mellon J; Apte R; Niederkorn JY
Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3218-25. PubMed ID: 7913917
[TBL] [Abstract][Full Text] [Related]
17. [Involvement of ICAM-1/LFA-1 adhesion molecule set in rat orthotopic liver transplantation].
Omura T
Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1220-31. PubMed ID: 7868060
[TBL] [Abstract][Full Text] [Related]
18. Induction of unresponsiveness to islet xenograft by MMC treatment of graft and blockage of LFA-1/ICAM-1 pathway.
Grochowiecki T; Gotoh M; Dono K; Takeda Y; Sakon M; Yagita H; Okumura K; Miyasaka M; Monden M
Transplantation; 2000 Apr; 69(8):1567-71. PubMed ID: 10836363
[TBL] [Abstract][Full Text] [Related]
19. Anti-LFA-1 alpha reduces the dose of cyclosporin A needed to produce immunosuppression in heterotopic cardiac transplanted rats.
Harrison PC; Madwed JB
J Heart Lung Transplant; 1999 Apr; 18(4):279-84. PubMed ID: 10226890
[TBL] [Abstract][Full Text] [Related]
20. LFA-1 and ICAM-1 antibody-idarubicin conjugates separately prolong murine cardiac allograft survival.
Pietersz GA; Sandrin MS; Ling S; Li YQ; McKenzie IFC
Transpl Immunol; 2001 Oct; 9(1):7-11. PubMed ID: 11680574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
